Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 13,737 | 8,889 | 4,467 | 1,578 |
| Operating Income | -13,737 | -8,889 | -4,467 | -1,578 |
| Interest Expense | 20 | 147 | 654 | 4 |
| Other Income | 2,596 | -7,449 | 0 | 0 |
| Pre-tax Income | -11,161 | -16,485 | -5,121 | -1,582 |
| Net Income Continuous | -11,161 | -16,485 | -5,121 | -1,582 |
| Net Income | $-11,161 | $-16,485 | $-5,121 | $-1,582 |
| EPS Basic Total Ops | -0.34 | -0.68 | -0.18 | N/A |
| EPS Basic Continuous Ops | -0.34 | -0.58 | -0.18 | N/A |
| EPS Diluted Total Ops | -0.34 | -0.68 | -0.18 | N/A |
| EPS Diluted Continuous Ops | -0.34 | -0.58 | -0.18 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.68 | N/A | N/A |
| EBITDA(a) | $-13,164 | $-8,371 | $-3,984 | $-1,578 |